🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a research study looking at Migranal (study drug) in the treatment ...
Status
Completed
Location
Jefferson Headache Center
Start Date
2006-08
Trial ID
NCT00335777
Treatments Being Tested
The objective of this study is to compare clinical efficacy and tolerabilit...
Status
Terminated
Location
University of Kentucky
Start Date
2017-10-03
Trial ID
NCT03885154
Treatments Being Tested
This is a phase 1 study, randomized, double-blind, placebo-controlled, 2 tr...
Status
Recruiting
Location
Sun City Clinical Research
Start Date
2026-05-26
Trial ID
NCT07665892
A Phase I clinical trial to compare the bioavailability of dihydroergotamin...
Status
Completed
Location
Centre for Clinical Studies/Nucleus Network
Start Date
2017-10-19
Trial ID
NCT03401346
Treatments Being Tested
This study is testing an investigational inhaled migraine medication to see...
Status
Recruiting
Location
Sunwise Clinical Research, Llc
Start Date
2026-05-19
Trial ID
NCT07646613
Single-center, single-dose, open-label, 2-part, 3-period crossover (in each...
Status
Completed
Location
Quotient Sciences Miami Inc.
Start Date
2018-09-11
Trial ID
NCT03874832
Treatments Being Tested
A Phase 1 clinical trial to evaluate the pharmacokinetics, relative bioavai...
Status
Completed
Location
Alliance for Multispecialty research (AMR)
Start Date
2025-06-09
Trial ID
NCT07226362
Compare the pharmacokinetics of Dihydroergotamine Mesylate (DHE) delivered ...
Status
Completed
Location
Simbec Research Limited
Start Date
2010-01
Trial ID
NCT01199965
Single-center, single-dose, open-label, 5-period crossover (in each part), ...
Status
Completed
Location
Quotient Sciences Miami Inc.
Start Date
2021-03-05
Trial ID
NCT05337254
Treatments Being Tested
This study consists of a 4-week screening period, a 24-week treatment perio...
Status
Completed
Location
Synexus - Clinical Research Advantage, Inc. - Simon Williamson Clinical, PC., 832 Princeton Avenue Southwest
Start Date
2018-07-13
Trial ID
NCT03557333
Treatments Being Tested